HCV ADVOCATE WEEKLY NEWS REVIEW

[Guest guest]

HCV ADVOCATE WEEKLY NEWS REVIEW

Week Ending: August 14, 2010

This Issue:

Treating Hepatitis B Runs Up Against Hmong Culture Hepatitis B Vaccination Reduces Prevalence In Drug Users New Anti-Viral Drug Shows Promise for Dramatic Improvement in Hepatitis C Treatment Phase 3 ILLUMINATE Study Supports 24-Week Telaprevir-Based Therapy Within a Response-Guided Regimen for People with Hepatitis C Who Had Not Received Prior Treatment Tattoos Increase Risk of Hepatitis C KERRY & HONDA: Disrupting a Deadly Disease Vertex: At the Finish Line for a Hepatitis C Cure Conquering HIV, Hepatitis C Requires Ongoing Research, Expert Says Boston Students Mobilize Community Partners to Screen Asian Americans for Hepatitis B Infergen Gives Hepatitis C Patients an Extra Chance Donor Dies after Live Liver Transplant at CU Hospital PSI-7977 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection Egypt Has Highest Incidence of Hepatitis C Worldwide Hepatitis C – More Treatment Options Announced by NICE Patient Who Was Treated with Reused Syringe Tests Negative for Hepatitis and HIV Boost for Drugs against Hepatitis C Clearfield-Jefferson Heroin Task Force Seeks Donations to Further Its Mission

http://www.hcvadvocate.org/news/newsRev/2010/NewsRev-374.html